Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
<b>Aim:</b> Doxorubicin (DOX) is used to treat various human cancers, but its use is limited due to its cardiotoxicity and heart failure effects. Pimobendan (PIMO) is used to treat heart failure. Although PIMO has been reported to suppress proinflammatory cytokines no studies have invest...
Saved in:
Main Authors: | Burak Dik, Orhan Çorum, Ayşe Er |
---|---|
Format: | Article |
Language: | English |
Published: |
Selcuk University Press
|
Series: | Eurasian Journal of Veterinary Sciences |
Subjects: | |
Online Access: | http://eurasianjvetsci.org/pdf.php3?id=1235 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01) -
Determination of protective effectiveness of nerium oleander distillation in doxorubicin-induced organ damages
by: Burak Dik, et al. -
Astaxanthin mitigates doxorubicin-induced cardiotoxicity via inhibiting ferroptosis and autophagy: a study based on bioinformatic analysis and in vivo/vitro experiments
by: Bowen Yin, et al.
Published: (2025-01-01) -
Investigation of cardiotoxic effects of marbofloxacin
by: Devran Coşkun, et al. -
Apelinergic System Affects Electrocardiographic Abnormalities Induced by Doxorubicin
by: Kasper Buczma, et al.
Published: (2025-01-01)